Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

University Hospital, Basel, Switzerland

19 clinical trials · 19 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by University Hospital, Basel, Switzerland

RECRUITINGNCT07355374

Balloon Dilation in Patients Undergoing Minimally Invasive Ivor Lewis Esophagectomy and Its Effect on Reducing DGCE

Background: Esophageal carcinoma ranks among the most common and lethal cancers worldwide. Minimally invasive esophagectomy is the standard curative treatment, but postoperative...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 1161 location
Delayed Gastric Conduit Emtpying (DGCE)Minimally-invasive Esophagectomy
RECRUITINGNCT02433028

Swiss Multiple Sclerosis Cohort-Study

The Swiss MS Cohort Study (SMSC) is a multicentre cohort study that involves 8 Swiss Multiple Sclerosis centres. The key aims of the SMSC are 1. To maintain a long-term cohort...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 12008 locations
Multiple Sclerosis
RECRUITINGNCT02142946

Quantified Balance Measures During Stance and Gait: Multiple Sclerosis Patients. A Longitudinal Clinical Study

The primary objective of this project is to track changes over time in balance control parameters measured during stance and gait for different groups of multiple sclerosis (MS)...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 3001 location
Balance Control
RECRUITINGNCT06369766

REtinal Markers In Neuroinflammatory Diseases ("REMIND")

The goal of this observational study, including patients with Multiple Sclerosis, patients with other neuroinflammatory diseases and healthy controls, is to determine the...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 5001 location
Multiple SclerosisNeuroinflammatory Diseases
RECRUITINGNCT06394180

PeRforation EVents During ENdovascular Therapy for Acute Ischemic Stroke

A large, worldwide study called PREVENT is looking at a complication that can happen during a stroke treatment called thrombectomy. This complication is a perforation of a blood...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 10001 location
Periprocedural Vessel PerforationAcute Ischemic Stroke
RECRUITINGNCT05662293

Characterization of Arrhythmia-induced Cardiomyopathy

The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 27001 location
CardiomyopathyArrhythmia-induced Cardiomyopathy (AiCM)
RECRUITINGPhase 2NCT05145283

Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events...

The aim of this trial is to assess the safety and efficacy of conestat alfa (Ruconest®, Pharming Technologies B.V.) on renal and cerebral ischemic events in patients undergoing...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 2502 locations
Acute Ischemic StrokeAcute Renal Injury
RECRUITINGNCT05885724

Novel Targetable BIOmarkers in ANorexia NervosA

The overall aim of this present study is to evaluate Growth Differentiation Factor-15 (GDF-15) and inflammatory cytokines as a possible novel and readily treatable target for the...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 321 location
Anorexia NervosaAnorexia Nervosa Restricting Type
RECRUITINGNCT06489899

Peer Education for Gender Inclusion and Substance Use in Southern Africa

The goal of this trial is to test the effectiveness of a brief, behavioral peer group intervention called "PEGISUS" (Peer Education for Gender Inclusion and Substance Use in...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 2643 locations
Substance UseGender Role
RECRUITINGNCT04359394

International Rare And Severe Psoriasis Expert Network

This registry is a prospective observational study in order to describe primarily the natural course of PP subtypes and to gain detailed information about their phenotype.

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 1808 locations
Pustular Psoriasis (PP)
RECRUITINGNCT05479448

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell...

This prospective study is to explore different predictive factors for response to steroid treatment in patients with PMR and/or GCA. It evaluates the association of endogenous GC...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 301 location
Polymyalgia Rheumatica (PMR)Giant Cell Arteritis (GCA)
RECRUITINGNCT06821802

Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis

The goal of this study is to assess the impact of protein supplementation on hyponatremia caused by the syndrome of inappropriate antidiuresis during hospitalization.

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 701 location
HyponatremiaSyndrome of Inappropriate Antidiuresis
RECRUITINGNCT05385237

Identification of Hepatic Fibrosis Using 4D-MRI

To date, no specific treatment options exist for liver diseases, and there is a large global effort to find drugs that will halt liver disease progression in these patients.Liver...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 2002 locations
Liver Diseases
RECRUITINGPhase 4NCT03153527

Taper Or Abrupt Steroid Stop: TOASSTtrial

This study is an Investigator-initiated, placebo-controlled, multicenter noninferiority trial, comparing rapid termination of systemic glucocorticoid treatment with a tapering...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 53016 locations
Inflammatory DisorderAutoimmune
RECRUITINGPhase 2NCT03805477

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

This study investigates the safety and tolerability of Nintedanib in patients with bronchiolitis obliterans syndrome (BOS) following allogeneic hematopoietic cell transplantation....

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 203 locations
Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
RECRUITINGPhase 2NCT05655091

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment...

This prospective randomized, controlled interventional pilot trial, aims to compare the achievement of the optimal target concentration with continuously administered...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 361 location
Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
RECRUITINGNCT04130789

Personalized Swiss Sepsis Study

This multi-center study is to focus on patients with sepsis in Intensive Care Units (ICUs) in order to better understand the complex host-pathogen interaction and clinical...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 1750016 locations
Sepsis
RECRUITINGPhase 4NCT04095572

Alternative Prophylaxis in Female Recurrent Urinary Tract Infections

Urological pathogens are effected by rising antimicrobial resistance rates due to the frequent use of antimicrobials for treatment and prophylaxis. Intravesical instillation with...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 502 locations
Urinary Tract InfectionsUrinary Tract Infection (UTI)
RECRUITINGNCT05017766

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria

This is an explorative, mono-center study including prospectively collected patient samples from the University Hospital of Basel. It is to investigate antimicrobial resistance...

Sponsor: University Hospital, Basel, SwitzerlandEnrolling: 80001 location
Antimicrobial Resistance (AMR)